Biotecnol and PolyTherics enter into a Research Collaboration for the Development of Tribody Antibody Drug Conjugates

Mercia EIS Funds | 28th October, 2012
Biotecnol and PolyTherics enter into a Research Collaboration for the Development of Tribody Antibody Drug Conjugates
Mercia EIS Funds | 18th October, 2012
Talking about the West Midlands European Regional Development Fund Programme
Mercia EIS Funds | 16th October, 2012
PolyTherics expands collaboration with a top five pharmaceutical company to enhance the clinical properties of biopharmaceuticals using PolyPEG
Mercia EIS Funds | 1st October, 2012
Talking university spin-outs – University of Warwick
Mercia EIS Funds | 26th September, 2012
Psioxus Launches Phase I/II Clinical Trial Of Oncolytic Vaccine With Dosing Of Patient With Metastatic Colorectal Cancer
Mercia EIS Funds | 13th September, 2012
Psioxus Therapeutics converts GBP 1 million in loan notes from the Wellcome Trust
Mercia EIS Funds | 12th September, 2012
Mercia Fund Management congratulates PsiOxus Therapeutics on Best Biotech Fund Raiser award
Mercia EIS Funds | 10th September, 2012
Pro Bono Bio obtains exclusive licence from PolyTherics
Mercia EIS Funds | 6th September, 2012
Looking at university spin-outs: University of Birmingham
Mercia EIS Funds | 21st August, 2012
PolyTherics appoints new head of business development